Showing results (401-410 of 565) with videos related to
Sort By:
Pageof 57
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 17, 2013
Treat to target: a proposed new paradigm for the management of Crohn's diseaseGuillaume Bouguen, Barrett G Levesque, Brian G Feagan, et al.Inflammatory Bowel Diseases|March 9, 2007
Smoking and inflammatory bowel disease: trends in familial and sporadic cohortsJeffrey A Tuvlin, Sania S Raza, Samuel Bracamonte, et al.Cell Host & Microbe|July 23, 2021
Multi-omics reveal microbial determinants impacting responses to biologic therapies in inflammatory bowel diseaseJonathan Wei Jie Lee, Damian Plichta, Larson Hogstrom, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 29, 2021
Dietary Gluten Intake Is Not Associated With Risk of Inflammatory Bowel Disease in US Adults Without Celiac DiseaseEmily W Lopes, Benjamin Lebwohl, Kristin E Burke, et al.Journal of the American Medical Informatics Association : JAMIA|November 11, 2017
Enabling phenotypic big data with PheNormSheng Yu, Yumeng Ma, Jessica Gronsbell, et al.JAMA Network Open|September 10, 2025
Comparative Safety of JAK Inhibitors vs TNF Antagonists in Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-AnalysisVirginia Solitano, Dhruv Ahuja, Han Hee Lee, et al.The American Journal of Gastroenterology|November 11, 2005
Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trialStephen B Hanauer, William J Sandborn, Asher Kornbluth, et al.Frontiers in Pharmacology|October 31, 2022
Atovaquone attenuates experimental colitis by reducing neutrophil infiltration of colonic mucosaLaura D Manzanares, Joseph David, Xingsheng Ren, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 15, 2015
Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future DirectionsLaurent Peyrin-Biroulet, Julián Panés, William J Sandborn, et al.The American Journal of Gastroenterology|February 28, 2007
The effects of infliximab therapy on health-related quality of life in ulcerative colitis patientsBrian G Feagan, Walter Reinisch, Paul Rutgeerts, et al.Pageof 57